| Date Filed | Type | Description |
| 04/02/2012 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 04/02/2012 |
8-K
| Quarterly results |
| 03/30/2012 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/29/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/27/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/27/2012 |
4
| PERRY MICHAEL S (President & CMO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,800 restricted stock units
@ $0 |
|
| 03/27/2012 |
4
| JACKSON MICHAEL K (Interim CFO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC. |
| 03/27/2012 |
4
| JACKSON MICHAEL K (Interim CFO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC. |
| 03/26/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/23/2012 |
RW
| Form RW - Registration Withdrawal Request |
| 03/22/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 02/23/2012 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 02/17/2012 |
4
| PERRY MICHAEL S (President & CMO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Sold 6,346 shares
@ $0.8679, valued at
$5.5k
|
|
| 02/17/2012 |
4
| JACKSON MICHAEL K (Interim CFO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Sold 2,401 shares
@ $0.8679, valued at
$2.1k
|
|
| 02/17/2012 |
4
| PERRY MICHAEL S (President & CMO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Exercised 12,019 restricted stock units
@ $0 |
|
| 02/17/2012 |
4
| JACKSON MICHAEL K (Interim CFO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Exercised 5,769 restricted stock units
@ $0 |
|
| 01/05/2012 |
8-K
| Form 8-K - Current report |
| 12/23/2011 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement... |
| 11/22/2011 |
8-K
| Form 8-K - Current report |
| 11/18/2011 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 11/10/2011 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 11/09/2011 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 11/04/2011 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/02/2011 |
8-K
| Form 8-K - Current report |
| 10/28/2011 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/28/2011 |
10-Q
| Quarterly Report for the period ended September 30, 2011 |
| 10/28/2011 |
425
| Form 425 - Prospectuses and communications, business combinations |
|